Cited by 330Intracranial Aneurysms: Treatment and ComplicationsImmunodeficiency and Autoimmune DisordersGenomics and Rare Diseases

The annual incidence of DiGeorge/velocardiofacial syndrome

Open access
Devriendt, K, Fryns, J P, Mortier, G, van Thienen, M N, Keymolen, K·1998·Journal of Medical Genetics

Abstract

Background The aim of this study was to assess the technical success and procedural safety of the new Silk Vista device (SV) by evaluating the intraprocedural and periprocedural complication rate after its use in several institutions worldwide. Methods The study involved a retrospective review of multicenter data regarding a consecutive series of patients with intracranial aneurysms, treated with the SV between September 2020 and January 2021. Clinical, intra/periprocedural and angiographic data, including approach, materials used, aneurysm size and location, device/s, technical details and initial angiographic aneurysm occlusion, were analyzed. Results 60 aneurysms were treated with SV in 57 procedures. 66 devices were used, 3 removed and 63 implanted. The devices opened instantaneously in 60 out of 66 (91%) cases and complete wall apposition was achieved in 58 out of 63 (92%) devices implanted. In 4 out of 66 (6%) devices a partial opening of the distal end occurred, and in 5 (8%) devices incomplete apposition was reported. There were 3 (5%) intraprocedural thromboembolic events managed successfully with no permanent neurological morbidity, and 4 (7%) postprocedural events. There was no mortality in this study. The initial occlusion rates in the 60 aneurysms were as follows: O’Kelly–Marotta (OKM) A in 34 (57%) cases, OKM B in 15 (25%) cases, OKM C in 6 (10%) cases, and OKM D in 5 (8%) cases. Conclusions Our study demonstrated that the use of the new flow diverter Silk Vista for the treatment of intracranial aneurysms is feasible and technically safe.

Integrity signals

Registry

Crossref · 10.1136/jmg.35.9.789-a

Cites

19 of 19 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Claims the paper makes

We couldn’t retrieve this paper’s full text, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Cites

Flagged first, then by citations

Cited by

Sorted by citations

Authors
Devriendt, K., Fryns, J. P., Mortier, G., van Thienen, M. N., & Keymolen, K.
Affiliations
  • St James's University Hospital (GB)
  • Universitair Ziekenhuis Leuven (BE)
Venue
Journal of Medical Genetics
Publisher
BMJ
Published
1998-09
Volume
35
Issue
9
Pages
789.2-790
ISSN
  • 0022-2593 (ISSN-L)
  • 1468-6244
OpenAlex
W2092107133
Cited by
330
References
19
Citations by year
2026: 1 · 2025: 6 · 2024: 5 · 2023: 4 · 2022: 7 · 2021: 19 · 2020: 14 · 2019: 15 · 2018: 17 · 2017: 18 · 2016: 15 · 2015: 15 · 2014: 11 · 2013: 16 · 2012: 14
FWCI
5.12
Type
journal article
Language
en
Open access
Locations
  • Journal of Medical Genetics (publishedVersion)
  • PubMed Central (publishedVersion)
  • PubMed (publishedVersion)
  • VUBIR (Vrije Universiteit Brussel) (submittedVersion)
  • Ghent University Academic Bibliography (Ghent University) (submittedVersion)
Funders
  • University College London
  • Medical Research Council
Topics
  • Health Sciences › Medicine › Neurology › Intracranial Aneurysms: Treatment and Complications
  • Life Sciences › Immunology and Microbiology › Immunology › Immunodeficiency and Autoimmune Disorders
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Genetics › Genomics and Rare Diseases
Keywords
annual incidence, intracranial aneurysm, flow diversion, technical success, procedural safety, intraprocedural complications, aneurysm occlusion
MeSH terms
Belgium, Child, Preschool, Chromosome Aberrations, Chromosome Deletion, Chromosomes, Human, Pair 22, DiGeorge Syndrome, Heart Defects, Congenital, Humans, Infant, Infant, Newborn, Syndrome, Incidence, Craniofacial Abnormalities, Chromosome Disorders

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review